Tag: OTCB:BTHCF

February 26, 2020

Algernon Pharmaceuticals to be Featured on BioPub Webcast Hosted by Dr. KSS MD PhD

Algernon Pharmaceuticals Inc. will be featured on an upcoming BioPub webcast hosted by Dr. KSS on Friday February 28th, 2020...
February 21, 2020

Algernon Pharmaceuticals Announces Increase and Closing of CDN$1.55M Private Placement

Algernon Pharmaceuticals (CSE:AGN) is pleased to announce that it has increased its previously announced non-brokered private placement of units.
February 13, 2020

Algernon Pharmaceuticals Announces Private Placement

Algernon Pharmaceuticals Inc. is pleased to announce it is undertaking a non-brokered private placement of up to CDN $1,200,000.
February 7, 2020

Algernon Pharmaceuticals Appoints Professor of Respiratory Medicine Dr. Jacky Smith to Its Medical and Scientific Advisory Board

Algernon Pharmaceuticals Inc. is pleased to announce that Dr. Jacky Smith has joined the Algernon Medical and Scientific Advisory Board.
January 17, 2020

Algernon: Repurposing Established Drugs to Create New Treatments

Algernon Pharmaceuticals Inc. (CSE:AGN; OTCQB:AGNPF; XFRA:AGW) has launched its campaign on the Investing News Network's life science channel. 
January 17, 2020

Algernon Pharmaceuticals Appoints Novotech as CRO for First Phase 2 Trial and Announces Novotech’s $220K Equity Investment

Algernon Pharmaceuticals is pleased to announce that it has appointed Novotech as the contract research organization for the Company’s upcoming...
December 30, 2019

Algernon Pharmaceuticals Announces OTC Trading Symbol Change to AGNPF

Algernon Pharmaceuticals is pleased to announced that the Financial Industry Regulatory Authority, has approved a change in the Company's stock...